Hepatoprotective agent

This page covers all Hepatoprotective agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Unknown.

Targets

Unknown

Marketed (1)

• Naïve patients - MNDL therapy · National Liver Institute, Egypt · Gastroenterology
  MNDL therapy involves the use of a specific compound to target and modulate the activity of a particular enzyme.